| scholarly article | Q13442814 |
| P2093 | author name string | James T Rutka | |
| Zhong-Ping Feng | |||
| Christopher L F Sun | |||
| Ji-Sun Kim | |||
| Ekaterina Turlova | |||
| Guan-Lei Wang | |||
| Hong-Shuo Sun | |||
| Xiao Zhong | |||
| Wen-Liang Chen | |||
| Yong-Yuan Guan | |||
| Sammen Huang | |||
| P2860 | cites work | TRPM7 is required for ovarian cancer cell growth, migration and invasion. | Q55069713 |
| Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. | Q55469941 | ||
| Design and synthesis of novel xyloketal derivatives and their vasorelaxing activities in rat thoracic aorta and angiogenic activities in zebrafish angiogenesis screen | Q84248713 | ||
| Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. | Q27824850 | ||
| Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia | Q28583854 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| Calcium signalling: dynamics, homeostasis and remodelling | Q29547635 | ||
| In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro | Q29617927 | ||
| Malignant astrocytic glioma: genetics, biology, and paths to treatment | Q29618156 | ||
| Identification of Ser/Thr phosphorylation sites in the C2-domain of phospholipase C γ2 (PLCγ2) using TRPM7-kinase | Q33726066 | ||
| Molecular interaction and functional regulation of ClC-3 by Ca2+/calmodulin-dependent protein kinase II (CaMKII) in human malignant glioma. | Q33799622 | ||
| Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates | Q34066507 | ||
| Involvement of Kv1.5 Protein in Oxidative Vascular Endothelial Cell Injury | Q34490473 | ||
| Clonogenic assay of cells in vitro. | Q34615431 | ||
| Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal study | Q34742606 | ||
| Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer | Q34996149 | ||
| Marine compound xyloketal B reduces neonatal hypoxic-ischemic brain injury | Q35015296 | ||
| TRPM7 regulates vascular endothelial cell adhesion and tube formation | Q35086271 | ||
| Development of novel targeted therapies in the treatment of malignant glioma | Q35770177 | ||
| TRPM7 regulates myosin IIA filament stability and protein localization by heavy chain phosphorylation | Q35971600 | ||
| Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge. | Q36003549 | ||
| Xyloketal B exhibits its antioxidant activity through induction of HO-1 in vascular endothelial cells and zebrafish. | Q36806721 | ||
| Molecularly targeted therapy for malignant glioma | Q36829847 | ||
| Structural alterations of the epidermal growth factor receptor gene in human gliomas | Q36930689 | ||
| Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2+ homeostasis | Q37019730 | ||
| Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian TRPM7 channels. | Q37187698 | ||
| Silencing TRPM7 promotes growth/proliferation and nitric oxide production of vascular endothelial cells via the ERK pathway | Q37258758 | ||
| Designer therapies for glioblastoma multiforme | Q37319650 | ||
| Synthesis and neuroprotective action of xyloketal derivatives in Parkinson's disease models | Q37425008 | ||
| Standards of care and novel approaches in the management of glioblastoma multiforme | Q37525881 | ||
| Targeting the AKT Pathway in Glioblastoma | Q37914262 | ||
| Ion channels and transporters in cancer. 5. Ion channels in control of cancer and cell apoptosis. | Q37937313 | ||
| RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy | Q37947586 | ||
| The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. | Q37996420 | ||
| Current clinical development of PI3K pathway inhibitors in glioblastoma | Q38012438 | ||
| The physiological roles of primary phospholipase C. | Q38138205 | ||
| Cellular and Developmental Biology of TRPM7 Channel-Kinase: Implicated Roles in Cancer | Q38235597 | ||
| Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells | Q38936421 | ||
| TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways | Q38959442 | ||
| ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity | Q39084326 | ||
| TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways | Q39108244 | ||
| Inhibition of TRPM7 channels prevents proliferation and differentiation of human lung fibroblasts | Q39112299 | ||
| TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway | Q39204198 | ||
| Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration. | Q39398553 | ||
| Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells. | Q39653276 | ||
| A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration | Q40192946 | ||
| Activation of TRPM7 channels by phospholipase C-coupled receptor agonists | Q40210138 | ||
| A key role for TRPM7 channels in anoxic neuronal death | Q40603687 | ||
| Genetic aberrations in human brain tumors | Q40659282 | ||
| Protective effects of xyloketal B against MPP+-induced neurotoxicity in Caenorhabditis elegans and PC12 cells | Q43116591 | ||
| Five unique compounds: xyloketals from mangrove fungus Xylaria sp. from the South China Sea coast. | Q43739167 | ||
| Overexpression of TRPM7 is associated with poor prognosis in human ovarian carcinoma | Q44064344 | ||
| Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells | Q44409595 | ||
| A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro | Q44815754 | ||
| Synthesis of xyloketal A, B, C, D, and G analogues | Q46936418 | ||
| Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice | Q48214498 | ||
| Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors | Q48445033 | ||
| Marine compound Xyloketal B protects PC12 cells against OGD-induced cell damage | Q48455374 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 2505-2525 | |
| P577 | publication date | 2015-04-22 | |
| P1433 | published in | Marine Drugs | Q2122804 |
| P1476 | title | Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K/Akt and MEK/ERK signaling pathways | |
| P478 | volume | 13 |
| Q92876695 | A Systematic Review of Recently Reported Marine Derived Natural Product Kinase Inhibitors |
| Q38722636 | Activation of TRPM7 by naltriben enhances migration and invasion of glioblastoma cells |
| Q88211297 | Blockade of the swelling-induced chloride current attenuates the mouse neonatal hypoxic-ischemic brain injury in vivo |
| Q37359778 | Carvacrol Alleviates Prostate Cancer Cell Proliferation, Migration, and Invasion through Regulation of PI3K/Akt and MAPK Signaling Pathways. |
| Q90335558 | Ion channels as therapeutic antibody targets |
| Q43239058 | Marine Compounds and Cancer: Where Do We Stand? |
| Q58588275 | Prostaglandin E2 increases migration and proliferation of human glioblastoma cells by activating transient receptor potential melastatin 7 channels |
| Q33851509 | Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic Target |
| Q48195180 | Role of TRPM7 in cerebral ischaemia and hypoxia. |
| Q48161755 | Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion |
| Q55251510 | TGFβ-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression. |
| Q89290583 | Transcriptional repression of human epidermal growth factor receptor 2 by ClC-3 Cl- /H+ transporter inhibition in human breast cancer cells |
| Q100385988 | Waixenicin A, a marine-derived TRPM7 inhibitor: a promising CNS drug lead |
| Q64112588 | Wound Healing Potential of Spirulina Protein on CCD-986sk Cells |
| Q36383780 | Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathway |
| Q88211300 | Xyloketal B exerts antihypertensive effect in renovascular hypertensive rats via the NO-sGC-cGMP pathway and calcium signaling |
Search more.